BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10331508)

  • 1. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.
    Ohga S; Kimura N; Takada H; Nagano M; Ohshima K; Nomura A; Muraoka K; Take H; Yamamori S; Hara T
    Am J Hematol; 1999 May; 61(1):26-33. PubMed ID: 10331508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal change of infiltrating T-cells in children with familial hemophagocytic lymphohistiocytosis: possible association with Epstein-Barr virus infection.
    Ishii E; Kimura N; Kato K; Sako M; Nagano M; Nakagawa A; Okamura T; Yamaguchi H; Kawa K; Hara T
    Cancer; 1999 Apr; 85(7):1636-43. PubMed ID: 10193957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection.
    Toyabe S; Harada W; Uchiyama M
    Clin Exp Immunol; 2003 Oct; 134(1):92-7. PubMed ID: 12974760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
    Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
    Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings.
    Iemura T; Kondo T; Hishizawa M; Yamashita K; Kimura H; Takaori-Kondo A
    Int J Infect Dis; 2019 Nov; 88():31-33. PubMed ID: 31398454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.
    Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T
    J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
    Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
    Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
    Front Immunol; 2018; 9():2291. PubMed ID: 30337929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
    Quintanilla-Martinez L; Kumar S; Fend F; Reyes E; Teruya-Feldstein J; Kingma DW; Sorbara L; Raffeld M; Straus SE; Jaffe ES
    Blood; 2000 Jul; 96(2):443-51. PubMed ID: 10887104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.
    Kawa-Ha K; Ishihara S; Ninomiya T; Yumura-Yagi K; Hara J; Murayama F; Tawa A; Hirai K
    J Clin Invest; 1989 Jul; 84(1):51-5. PubMed ID: 2544630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.
    Ohshima K; Karube K; Hamasaki M; Tutiya T; Yamaguchi T; Suefuji H; Suzuki K; Suzumiya J; Ohga S; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1367-78. PubMed ID: 12952231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection.
    Ohga S; Takada H; Honda K; Inamura T; Gondo K; Ohshima K; Yamamoto M; Hara T
    J Pediatr Hematol Oncol; 1999; 21(1):42-6. PubMed ID: 10029811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated T-cell lymphoproliferative disorder affecting skin and lung in an elderly patient.
    Hoshino T; Tatsuno K; Shimauchi T; Okada S; Ito T; Ono T; Ohshima K; Tokura Y
    J Dermatol; 2014 Sep; 41(9):837-40. PubMed ID: 25109697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.